(Hypertension. 1999;33:548-553.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the Division of Pediatric Cardiology (A.P.R.), University of Michigan (Ann Arbor); Division of Pediatric Cardiology (P.M.), Department of Pediatrics, University of Minnesota (Minneapolis); and Division of Pediatric Cardiology (H.Z.M., A.J.R., K.B.), Children's Memorial Hospital and Northwestern University, Chicago, Ill.
Correspondence to Albert P. Rocchini, MD, Pediatric Cardiology, C.S. Mott Hospital, University of Michigan Medical Center, F1310 MCHC, Box 0204, 1500 East Medical Center Dr, Ann Arbor, MI 48109-0204. E-mail rocchini{at}umich.edu
AbstractThe role that the central sympathetic nervous system plays in the development of obesity hypertension and insulin was evaluated by feeding dogs a high fat diet with or without clonidine treatment. Thirteen adult mongrel dogs were chronically instrumented and randomly assigned to receive either a high fat diet and no clonidine (n=6) or a high fat diet plus clonidine (n=7), 0.3 mg BID. Blood pressure, heart rate, plasma insulin, and electrolytes were measured daily. Insulin resistance was assessed with a multiple-dose euglycemic clamp (1, 2, and 30 mU · kg-1 · min-1) before and after 1, 3, and 6 weeks of the high fat diet. Clonidine prevented the hypertension, tachycardia, and insulin resistance associated with feeding dogs the high fat diet but did not affect weight gain. The present study suggests that the central sympathetic nervous system plays a critical role in the development of both insulin resistance and hypertension associated with feeding dogs a high fat diet.
Key Words: hypertension, arterial obesity insulin resistance clonidine sympathetic nervous system cardiac output
This article has been cited by other articles:
![]() |
S. D. Stocker, R. Meador, and J. M. Adams Neurons of the Rostral Ventrolateral Medulla Contribute to Obesity-Induced Hypertension in Rats Hypertension, March 1, 2007; 49(3): 640 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Shibao, A. Gamboa, A. Diedrich, A. C. Ertl, K. Y. Chen, D. W. Byrne, G. Farley, S. Y. Paranjape, S. N. Davis, and I. Biaggioni Autonomic Contribution to Blood Pressure and Metabolism in Obesity Hypertension, January 1, 2007; 49(1): 27 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Carroll, W. J. Zenebe, and T. B. Strange Cardiovascular Function in a Rat Model of Diet-Induced Obesity Hypertension, July 1, 2006; 48(1): 65 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kotsis, S. Stabouli, M. Bouldin, A. Low, S. Toumanidis, and N. Zakopoulos Impact of Obesity on 24-Hour Ambulatory Blood Pressure and Hypertension Hypertension, April 1, 2005; 45(4): 602 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Hafidi, I. Perez, J. Zamora, V. Soto, G. Carvajal-Sandoval, and G. Banos Glycine intake decreases plasma free fatty acids, adipose cell size, and blood pressure in sucrose-fed rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1387 - R1393. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Rand, L. M. Fleeman, H. A. Farrow, D. J. Appleton, and R. Lederer Canine and Feline Diabetes Mellitus: Nature or Nurture? J. Nutr., August 1, 2004; 134(8): 2072S - 2080S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Sharma Is There a Rationale for Angiotensin Blockade in the Management of Obesity Hypertension? Hypertension, July 1, 2004; 44(1): 12 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Rocchini, J. Q. Yang, and A. Gokee Hypertension and Insulin Resistance Are Not Directly Related in Obese Dogs Hypertension, May 1, 2004; 43(5): 1011 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Kuo, A. A. da Silva, L. S. Tallam, and J. E. Hall Role of Adrenergic Activity in Pressor Responses to Chronic Melanocortin Receptor Activation Hypertension, February 1, 2004; 43(2): 370 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aneja, F. El-Atat, S. I. McFarlane, and J. R. Sowers Hypertension and Obesity Recent Prog. Horm. Res., January 1, 2004; 59(1): 169 - 205. [Abstract] [Full Text] |
||||
![]() |
R. B. de Paula, A. A. da Silva, and J. E. Hall Aldosterone Antagonism Attenuates Obesity-Induced Hypertension and Glomerular Hyperfiltration Hypertension, January 1, 2004; 43(1): 41 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Strazzullo, F. Galletti, and G. Barba Altered Renal Handling of Sodium in Human Hypertension: Short Review of the Evidence Hypertension, May 1, 2003; 41(5): 1000 - 1005. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Carlyle, O. B. Jones, J. J. Kuo, and J. E. Hall Chronic Cardiovascular and Renal Actions of Leptin: Role of Adrenergic Activity Hypertension, February 1, 2002; 39(2): 496 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Grandi, P. Zanzi, R. Broggi, A. Fachinetti, L. Guasti, L. Ceriani, and A. Venco Longitudinal Changes of Insulin Sensitivity in Essential Hypertension: Influence of Blood Pressure Control and Familial Predisposition to Hypertension J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3027 - 3031. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Stojiljkovic, D. Zhang, H. F. Lopes, C. G. Lee, T. L. Goodfriend, and B. M. Egan Hemodynamic effects of lipids in humans Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2001; 280(6): R1674 - R1679. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |